Quick answers
- What is Selarsdi?
- Selarsdi is a brand name of Ustekinumab-aekn and Ustekinumab, a prescription medicine. The FDA NDC Directory lists 4 Selarsdi products in 4 strengths and forms.
- Who makes Selarsdi?
- Alvotech USA Inc holds the FDA application for Selarsdi (BLA761343, approved April 16, 2024). 1 other company (repackagers or distributors) also list Selarsdi products.
- Is there a generic or store brand of Selarsdi?
- Yes. The FDA NDC Directory lists 15 other products with the same active ingredients, strength and form as a Selarsdi product. Ask your pharmacist whether one is right for you.
- Has Selarsdi been recalled?
- No recall linked to Selarsdi products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Selarsdi is
Each Selarsdi product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Ustekinumab-aekn · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| ustekinumab-aekn 130 mg/26 mL injection, solution (intravenous) | Selarsdi | None listed | DailyMed |
| ustekinumab-aekn 45 mg/0.5 mL injection, solution (subcutaneous) | Selarsdi | 2 products, 1 company | DailyMed |
| ustekinumab-aekn 90 mg/mL injection, solution (subcutaneous) | Selarsdi | 2 products, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Ustekinumab-aekn →
Ustekinumab · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| ustekinumab 90 mg/mL injection, solution (subcutaneous) | Selarsdi | 11 products, 8 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Ustekinumab →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| BLA761343 | Alvotech USA Inc | April 16, 2024 | 4 |
Companies that list Selarsdi
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Selarsdi products.
- Teva Pharmaceuticals USA, Inc.3 products
- A-S Medication Solutions1 product
Recalls
No recall linked to Selarsdi products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.